ATRASENTAN FOR THE TREATMENT OF IGA NEPHROPATHY: INTERIM RESULTS OF THE AFFINITY STUDY
Back
Abstract Number
WCN23-1126
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
ATRASENTAN FOR THE TREATMENT OF IGA NEPHROPATHY: INTERIM RESULTS OF THE AFFINITY STUDY
Co-authors
Kim, S.G.(1)*;Inker, L.A.(2);Packham, D.K.(3);Ranganatha, D.(4);Rastogi, A.(5);Rheault, M.N.(6);Vishnepolsky, M.(7);Sheth, K.(8);DeVries, T.(9);Camargo, M.(8);King, A.J.(10);Jones-Burton, C.(8);Han, S.H.(11);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Hallym University Sacred Heart Hospital, Nephrology Division, Gyeonggi-do, South Korea;(2)Tufts Medical Center, Department of Medicine, Boston, United States;(3)Melbourne Renal Research Group, Nephrology, Reservoir, Australia;(4)Royal Brisbane and Women's Hospital, Renal Medicine, Herston, Australia;(5)University of California Los Angeles, Nephrology, Los Angeles, United States;(6)University of Minnesota, Division of Nephrology, Minneapolis, United States;(7)Kidney Specialists of Southern Nevada, Nephrology, Las Vegas, United States;(8)Chinook Therapeutics- Inc, Clinical Development, Seattle, United States;(9)Chinook Therapeutics- Inc, Biometrics, Seattle, United States;(10)Chinook Therapeutics- Inc, Biology, Seattle, United States;(11)Yonsei University College of Medicine, Division of Nephrology, Seoul, South Korea;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/15b2fbc63bdb9c7dd8ff481fd7928777.pdf
Audio File
if any